Therapeutic Solutions International (TSOI) Stock Price, News & Analysis

Company Overview

Therapeutic Solutions International, Inc. (OTCMKTS:TSOI) is a clinical-stage biotechnology company focused on discovering, developing and commercializing innovative small-molecule therapeutics for the treatment of cancer, neurological disorders and inflammatory diseases. The company’s core expertise lies in medicinal chemistry and preclinical pharmacology, enabling the advancement of multiple proprietary drug candidates from early discovery through regulatory submission. TSOI’s pipeline includes lead compounds designed to target key molecular pathways implicated in tumor growth and neurodegeneration, as well as novel anti-inflammatory agents aimed at chronic conditions with high unmet medical needs.

Since its founding in 2011, TSOI has established research operations in Tampa, Florida, with satellite laboratories in Austin, Texas, and collaborative partnerships with academic institutions in North Carolina’s Research Triangle. These geographic footprints support both in-house discovery work and external contract research activities, including formulation development and toxicology testing. The company maintains strategic alliances with university spin-outs and contract research organizations to accelerate candidate validation and manufacturing scale-up ahead of human clinical trials.

Under the leadership of CEO and Board Chairman George Massimi, who brings over two decades of experience in life-sciences management and drug development, Therapeutic Solutions International has grown its executive team to include seasoned experts in clinical operations, regulatory affairs and business development. CEO Massimi is supported by Chief Scientific Officer Dr. Jeanette Gomez, whose background in kinase biology has guided the design of TSOI’s oncology compounds, and CFO Kyle Smith, who oversees financial planning and strategic investor relations. Together, this leadership cadre continues to drive the company’s mission to create differentiated therapeutics that address significant global healthcare challenges.

Key Stats

• Today's Range: $0.0001 to $0.0002
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.0009
• Volume: 11.30 million shs
• Average Volume: 25.06 million shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

TSOI Stock Analysis - Frequently Asked Questions

How have TSOI shares performed this year?

Therapeutic Solutions International's stock was trading at $0.0002 at the beginning of the year. Since then, TSOI stock has decreased by 50.0% and is now trading at $0.0001.

How do I buy shares of Therapeutic Solutions International?

Shares of TSOI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Therapeutic Solutions International own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Therapeutic Solutions International investors own include Creative Medical Technology (CELZ), Hon Hai Precision Industry Co., Ltd. Sponsored GDR (HNHPF), Zevra Therapeutics (ZVRA), CAS Medical Systems (CASM), CRISPR Therapeutics (CRSP), Trevena (TRVN) and Alamos Gold (AGI).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:TSOI
• CIK: 1419051
• Web: therapeuticsolutionsint.com
• Phone: (760) 295-7208
• Fax: N/A
• Employees: 3
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A